文献速递认知障碍与痴呆

老年人四重错误折叠蛋白的患病率与临床表型

Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults.
PubMed 文献 · JAMA Neurol · 2020-01-01

这项回顾性尸检队列研究纳入375名社区老年人,发现12.3%存在tau、Aβ、α-突触核蛋白和TDP-43四重错误折叠蛋白,其中痴呆者占19.2%。四重蛋白组痴呆比例最高(89.1%),末次MMSE均分最低(13.4分),APOE ε4携带者风险增高。

要点

  • 四重错误折叠蛋白在社区尸检队列中占12.3%,痴呆者中占19.2%。
  • 四重蛋白组痴呆比例89.1%,末次MMSE均分13.4分,认知轨迹最差。
  • APOE ε4与四重蛋白风险增高相关(aOR 2.55)。

核心结论

  • 四重错误折叠蛋白是认知损害的常见病理基础,与侵袭性病程相关,常以重度痴呆告终。
  • α-突触核蛋白和TDP-43与阿尔茨海默病病理共存可能增加治疗和预防难度。

研究设计与样本

  • 回顾性队列研究,使用肯塔基大学阿尔茨海默病中心脑库尸检数据。
  • 纳入1989年1月1日至2017年12月31日入组的社区老年人,基线年龄≥55岁,平均随访10.4年。
  • 最终样本375人,死亡时平均年龄86.9岁(SD 8.0),女性232人(61.9%)。

主要发现

  • 214名痴呆者中41人(19.2%)检出四重错误折叠蛋白。
  • 总体46人(12.3%)有四重蛋白,143人(38.1%)有三种蛋白病。
  • 四重蛋白组痴呆比例最高(41/46,89.1%),末次MMSE均分最低(13.4,SD 9.8)。
  • 四重蛋白组在死亡前12年内获得正常认知MMSE(27-30分)的概率最低,严重损害MMSE(≤13分)的概率最高。

临床怎么用

  • 对痴呆患者应关注多种蛋白病共存可能,四重蛋白表型提示更差认知轨迹。
  • APOE ε4携带者需警惕四重蛋白风险,但需进一步验证。

局限性

  • 回顾性尸检队列研究,来自单一中心社区队列,结果外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Quadruple misfolded proteins (tau neurofibrillary tangles, amyloid-β [Aβ], α-synuclein, and transactive response DNA-binding protein 43 [TDP-43]) in the same brain are relatively common in aging. However, the clinical presentation, associated factors, frequency in community-based cohorts, genetic characteristics, and cognitive trajectories associated with the quadruple misfolded proteins phenotype are not well understood. OBJECTIVE: To describe the quadruple misfolded proteins phenotype, including the trajectories of global cognition, in an autopsy cohort. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used brain autopsy data from the University of Kentucky Alzheimer Disease Center (UK-ADC) Brain Bank. Participants were deceased individuals who were enrolled in a longitudinal community-based cohort study of aging and dementia in central Kentucky conducted by the UK-ADC. Included participants were enrolled in the UK-ADC cohort between January 1, 1989, and December 31, 2017; aged 55 years or older at baseline; and followed up for a mean duration of 10.4 years. The participants had Alzheimer disease pathology (tau and Aβ), α-synuclein, and TDP-43 data, along with Braak neurofibrillary tangle stage I to VI. Data analysis was conducted between February 1, 2019, and September 30, 2019. MAIN OUTCOMES AND MEASURES: Frequency of quadruple misfolded proteins was estimated, and proteinopathy group characteristics and associations with global cognition were evaluated. Multinomial logistic regression was used to estimate the association of proteinopathy group with participant characteristics, including age at death, sex, and apolipoprotein ε4 (APOE ε4) allele. Generalized estimating equations were used to estimate the probability of obtaining Mini-Mental State Examination (MMSE) scores within the normal cognition (27-30 points) and severe impairment (≤13 points) ranges during the 12 years before death. RESULTS: The final sample included 375 individuals (mean [SD] age at death, 86.9 [8.0] years); 232 women [61.9%]). Quadruple misfolded proteins were detected in 41 of 214 individuals with dementia (19.2%). Overall, 46 individuals (12.3%) had quadruple misfolded proteins, whereas 143 individuals (38.1%) had 3 proteinopathies. Dementia frequency was highest among those with quadruple misfolded proteins (41 [89.1%]), and participants with quadruple misfolded proteins had the lowest final mean (SD) MMSE scores of 13.4 (9.8) points. Adjusting for age at death and sex, the APOE ε4 allele was associated with higher odds of quadruple misfolded proteins (adjusted odds ratio, 2.55; 95% CI, 1.16- 5.62; P = .02). The quadruple misfolded proteins group had both the lowest probability of obtaining MMSE scores in the normal cognition range, even 12 years before death, and the highest probability of having MMSE scores in the severe impairment range. CONCLUSIONS AND RELEVANCE: Quadruple misfolded proteins appear to be a common substrate for cognitive impairment and to be associated with an aggressive course of disease that typically ends with severe dementia. The prevalence of comorbid α-synuclein and TDP-43 with Alzheimer disease pathology (tau and Aβ) may complicate efforts to identify therapies to treat and prevent Alzheimer disease.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Karanth S, Nelson PT, Katsumata Y, et al. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. JAMA Neurol. 2020. PMID: 32568358. doi:10.1001/jamaneurol.2020.1741

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。